RMD vs RYAM · P/E 29, rev $5.65B vs rev $695.2M
ResMed Inc (RMD) versus Rayonier Advanced Materials (RYAM) — a side-by-side from cached financials, not a winner call.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Rayonier Advanced Materials (RYAM) is a chemicals company listed on US.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Latest reported RYAM revenue for 2026-06-27 was $695.2M. Net income was -$114.4M. RYAM currently screens at market cap $242.4M.
RMD currently screens at market cap $37.68B and trailing P/E 28.8. RYAM currently screens at market cap $242.4M.
Not investment advice. Open the RMD and RYAM stock pages for the full models.
Not investment advice.